Search Results 341-350 of 16025 for pharmacogenetics
About this study. The primary objective of the study is to compare outcomes of patients undergoing sarcoma reconstructive surgery using fluorescence ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
About this study. The purpose of this study is to develop a resource (bank) of biospecimens and data collected from individuals with functional ...
Use of pharmacogenetic data to guide individualized opioid prescribing after surgery. Surgery. 2019 Oct; 166 (4):476-482 Epub 2019 July 15. View PubMed ...
Dr. Miller's lab studies the class A cholecystokinin receptor and the class B secretin receptor, with a goal of advancing the development of receptor-active ...
Education. Mayo Clinic is committed to advancing the science of medicine by training and mentoring the next generation of clinicians and scientists — the ...
Contact information for Mayo Clinic's Drug Discovery, Design and Optimization for Novel Therapeutics Lab led by Thomas Caulfield, Ph.D., in Florida.
The purpose of this study is to to investigate if variable phenotypic expression, with the same genotype, could be explained by mtDNA haplotype variations. A ...
Researchers also demonstrated the ability to study race and racial admixture more accurately using DNA analysis. The findings were published in Blood Cancer ...
A secondary objective of this study is to evaluate the comparative bioavailability of treprostinil between two formulations of inhaled therapy. Participation ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.